Healthcare >> Analyst Interviews >> November 24, 2003

Life Science Enabling Tools: Kenneth Goldman – Lehman Brothers

DR. KENNETH GOLDMAN is a Vice President and Equity Analyst with Lehman Brothers. His research coverage is focused on the life science enabling tools sector. Prior to his tenure at Lehman Brothers, Dr. Goldman was the Director of the Cornea Transplant Service and an Associate Clinical Professor of Ophthalmology at the Albert Einstein School of Medicine. He has performed basic research in corneal physiology, invented patented surgical instruments and directed the launch and development of a multi- site eye-care system for a New York managed care organization. Dr. Goldman is a Phi Beta Kappa graduate of Union College, Schenectady, New York. He received his MD degree from the New York University School of Medicine and his MBA with distinction from Columbia University School of Business. Profile
TWST: Could we start out with a quick overview of your coverage?

Dr. Goldman: I cover the life science enabling tool space. These are the

companies that make specialized analytical instruments